Physician profile
Shane Patrick Duggan
NPI 1417687724
$7,109.93
in general payments reported to CMS, 2019-2025
16 companies · $4,651 in 2025
The $4,651 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $662 · 2024: $1,796 · 2025: $4,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,382 · Travel and Lodging: $2,394 · Education: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,381.85 |
| Travel and Lodging | $2,393.60 |
| Education | $334.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,932.30 | 2023-2025 | Infinity, Dart-Fire, Infinity Adaptis |
| Arthrex, INC. | $1,009.90 | 2025 | |
| Sioux Surgical INC | $868.02 | 2025 | |
| Treace Medical Concepts, INC. | $628.78 | 2025 | |
| Medical Device Business Services, INC. | $334.48 | 2024 | |
| Smith+Nephew, INC. | $294.67 | 2024-2025 | Stravix, Grafix, Oasis |
| Depuy Synthes Sales INC. | $192.80 | 2024-2025 | Va-Lcp, Motoband, Na |
| Sanara Medtech INC. | $177.52 | 2025 | Celleraterx |
| Davol INC. | $147.80 | 2025 | Arista |
| My01 INC. | $137.28 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Kerecis Limited | $135.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $99.79 | 2024-2025 | Novosorb Btm |
| Mimedx Group, INC. | $66.83 | 2025 | |
| Oxford Performance Materials, INC. | $42.37 | 2024 | |
| Paragon 28, INC. | $22.73 | 2025 | Phantom Fibula Nail |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19.00 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Duggan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.